#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	667	660	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1056	33.5	0	.	p	.	0	K29T	NONSYN	85	87	AAG	294	296	ACG	28;27;28	A;C;G	28;27;28	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	667	660	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1056	33.5	0	HET	.	.	.	A479T	.	479	479	A	688	688	A	47	A,T	32,14	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	T879G	SNP	879	879	T	17	17	G	6	G	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	G880A	SNP	880	880	G	18	18	A	6	A	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	A888G	SNP	888	888	A	26	26	G	13	G	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	C897G	SNP	897	897	C	35	35	G	20	G	20	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	T898C	SNP	898	898	T	36	36	C	20	C	20	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	G906T	SNP	906	906	G	44	44	T	27	T	27	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	G908A	SNP	908	908	G	46	46	A	30	A	30	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	A918T	SNP	918	918	A	56	56	T	32	T	32	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	A943G	SNP	943	943	A	81	81	G	53	G	53	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	412	Chlamydophila_psittaci_16S	1507	137	91.24	Chlamydophila_psittaci_16S.l15.c30.ctg.1	147	29.3	0	.	n	.	0	G991T	SNP	991	991	G	129	129	T	44	T	44	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1176	1178	AGC	40;39;39	A,G;G;C	29,11;39;39	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	L121Q	0	.	.	361	363	CTG	357	359	CTG	109;109;104	C;T;G	108;108;103	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	Q125K	0	.	.	373	375	CAG	369	371	CAG	110;108;109	C;A;G,C	109;106;108,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	Q125E	0	.	.	373	375	CAG	369	371	CAG	110;108;109	C;A;G,C	109;106;108,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	Q125R	0	.	.	373	375	CAG	369	371	CAG	110;108;109	C;A;G,C	109;106;108,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	Y161D	0	.	.	481	483	TAC	477	479	TAC	118;117;120	T;A;C,T	117;117;119,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	Y161N	0	.	.	481	483	TAC	477	479	TAC	118;117;120	T;A;C,T	117;117;119,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	Y161C	0	.	.	481	483	TAC	477	479	TAC	118;117;120	T;A;C,T	117;117;119,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	G317D	0	.	.	949	951	GGC	945	947	GGC	132;130;128	G;G;C	131;130;127	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1122	1124	GCA	94;93;94	G,C;C;A	89,1;87;92	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1122	1124	GCA	94;93;94	G,C;C;A	89,1;87;92	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1131	1133	GAA	100;98;97	G;A,G;A	99;97,1;96	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	0	HET	.	.	.	T135C	.	135	135	T	131	131	T	66	T,C	39,21	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	0	HET	.	.	.	C210T	.	210	210	C	206	206	C	92	C,T	43,48	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	2608	Escherichia_coli_EF_Tu	1185	1181	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1360	95.7	0	HET	.	.	.	C99T	.	99	99	C	95	95	C	75	C,T	47,27	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	898	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c4.ctg.1	1861	25.9	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1577	1579	AAA	7;6;5	A;A;A	7;6;5	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	252	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	885	15.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	T50C	SNP	50	50	T	98	98	C	39	C	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	G74A	SNP	74	74	G	122	122	A	4	A	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	A83C	SNP	83	83	A	130	130	C	5	C	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	T93G	SNP	93	93	T	139	139	G	4	G	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	T97C	SNP	97	97	T	143	143	C	5	C	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	T128C	SNP	128	128	T	174	174	C	33	C	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	T135A	SNP	135	135	T	181	181	A	40	A	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	G139C	SNP	139	139	G	185	185	C	40	C	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	T142G	SNP	142	142	T	188	188	G	40	G	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	G159A	SNP	159	159	G	205	205	A	35	A,C	34,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	G161T	SNP	161	161	G	207	207	T	34	T	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	T168G	SNP	168	168	T	214	214	G	25	G	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.11	232	31.2	0	.	n	.	0	C170T	SNP	170	170	C	216	216	T	23	T	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	249	G	246	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	240	C	240	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	212	C	212	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	172	T	171	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	163	C	163	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	121	C	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	137	A	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	138	A	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	144	A	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	157	T	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	158	C	158	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	151	C	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	151	A	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	168	G	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	176	C,T,G	173,1,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	207	T	207	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	239	G	239	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	249	G	249	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	260	T,C	257,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	182	T,A	180,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	172	G	171	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	138	C	137	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	129	A	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	91	C	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	81	C	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	12	A	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	11	A	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	8	G	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	17	C	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	80	T	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	90	G	90	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	74	T	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	534	170.0	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	175	C	174	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.8	142	23.8	0	.	n	.	0	C990G	SNP	990	990	C	40	40	G	29	G,A	28,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.8	142	23.8	0	.	n	.	0	T1002A	SNP	1002	1002	T	52	52	A	34	A	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.8	142	23.8	0	.	n	.	0	A1004G	SNP	1004	1004	A	54	54	G	34	G	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.8	142	23.8	0	.	n	.	0	C1011T	SNP	1011	1011	C	61	61	T	34	T	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.8	142	23.8	0	.	n	.	0	C1023A	SNP	1023	1023	C	73	73	A	40	A	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.8	142	23.8	0	.	n	.	0	T1024A	SNP	1024	1024	T	74	74	A	37	A	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.8	142	23.8	0	.	n	.	0	T1041G	SNP	1041	1041	T	91	91	G	39	G	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.8	142	23.8	0	.	n	.	0	A1042T	SNP	1042	1042	A	92	92	T	37	T	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	88	97.73	Pasteurella_multocida_16S.l15.c4.ctg.9	94	108.7	0	.	n	.	0	A303G	SNP	303	303	A	9	9	G	53	G	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3400	Pasteurella_multocida_16S	1551	88	97.73	Pasteurella_multocida_16S.l15.c4.ctg.9	94	108.7	0	.	n	.	0	G375A	SNP	375	375	G	81	81	A	51	A	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	972	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1550	33.8	0	.	p	.	0	H2R	NONSYN	4	6	CAT	258	260	CGT	34;33;32	C;G;T	34;32;31	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	972	PmrB_1	1092	1092	99.27	PmrB_1.l15.c4.ctg.1	1550	33.8	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1101	1103	GGC	44;43;44	G;G;C	44;42;44	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2036	37.6	0	.	p	.	0	R8S	NONSYN	22	24	AGA	239	241	AGC	17;15;15	A,C;G;C	16,1;15;15	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2036	37.6	0	.	p	.	0	I142L	NONSYN	424	426	ATA	641	643	CTA	36;35;34	C;T;A	36;35;34	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2036	37.6	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1160	1162	CAA	45;48;49	C;A;A	45;48;49	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2036	37.6	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1259	1261	GGT	62;61;61	G;G;T	62;61;61	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1426	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2036	37.6	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1829	1831	GTT	26;25;23	G;T;T	26;25;22	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	670	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1658	21.7	0	.	p	.	0	A125E	NONSYN	373	375	GCA	655	657	GAA	29;30;30	G;A;A	29;30;30	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	670	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1658	21.7	0	.	p	.	0	M185T	NONSYN	553	555	ATG	835	837	ACC	12;12;11	A;C;C	12;12;11	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	670	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1658	21.7	0	.	p	.	0	S225T	NONSYN	673	675	TCC	955	957	ACT	24;23;23	A;C;T	23;23;23	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	670	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1658	21.7	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1345	1347	ATC	10;10;10	A;T;C	10;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	720	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1468	26.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2222	acrD	3114	3114	99.1	acrD.l15.c17.ctg.1	3489	34.2	0	.	p	.	0	T85I	NONSYN	253	255	ACC	460	462	ATC	40;40;37	A;T;C	40;40;37	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2222	acrD	3114	3114	99.1	acrD.l15.c17.ctg.1	3489	34.2	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2173	2175	AAG	24;24;25	A;A;G	24;24;25	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	970	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1601	32.5	0	.	p	.	0	A22V	NONSYN	64	66	GCC	300	302	GTC	4;4;5	G;T;C	4;4;5	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	970	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1601	32.5	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1041	1043	TGC	47;47;47	T;G;C	47;47;46	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2690	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3588	40.1	0	.	p	.	0	S46trunc	TRUNC	136	136	T	377	377	T	23	T	23	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2690	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3588	40.1	0	.	p	.	0	G148D	NONSYN	442	444	GGC	683	685	GAC	56;54;55	G;A;C	56;53;54	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2690	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3588	40.1	0	.	p	.	0	F240L	NONSYN	718	720	TTT	959	961	TTA	10;10;11	T;T;A	10;10;11	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2690	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3588	40.1	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2036	2038	AAT	47;49;48	A;A;T	47;49;48	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2690	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3588	40.1	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2150	2152	AGT	39;38;38	A;G;T	39;38;38	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2690	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3588	40.1	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2549	2551	GTG	33;32;31	G;T;G	32;29;31	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2690	acrF	3105	3105	98.78	acrF.l6.c30.ctg.1	3588	40.1	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3104	3106	AAG	48;47;49	A;A;G	48;47;49	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	538	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1099	26.4	1	SNP	p	R45C	0	.	.	133	135	CGC	364	366	CGC	36;36;35	C;G;C	35;36;35	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	530	acrS	663	663	98.79	acrS.l15.c30.ctg.1	935	30.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	185	187	TTC	26;25;26	T;T;C	26;25;26	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	530	acrS	663	663	98.79	acrS.l15.c30.ctg.1	935	30.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	449	451	GGG	32;34;35	G;G;G,A	32;34;34,1	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	754	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1145	35.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	584	586	CTT	50;50;53	C;T,G;T	50;49,1;53	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2298	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3109	39.8	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2090	2092	GCA	47;47;48	G;C;A	47;47;48	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2298	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3109	39.8	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2351	2353	ACC	44;45;46	A;C;C	43;45;46	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2298	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3109	39.8	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2660	2662	GCC	32;30;32	G;C;C	32;28;32	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1104	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2246	26.3	0	.	p	.	0	G37A	NONSYN	109	111	GGT	181	183	GCT	4;4;6	G;C;T	4;4;6	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1104	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2246	26.3	0	.	p	.	0	D77E	NONSYN	229	231	GAT	301	303	GAG	12;12;13	G;A;G	12;12;13	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1104	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2246	26.3	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	337	339	TGC	6;6;6	T;G;C	6;6;6	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1104	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2246	26.3	0	.	p	.	0	I150V	NONSYN	448	450	ATT	520	522	GTT	18;18;20	G;T;T	18;18;20	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1104	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2246	26.3	0	.	p	.	0	R200H	NONSYN	598	600	CGC	670	672	CAC	20;20;20	C;A;C	20;20;20	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1104	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2246	26.3	0	.	p	.	0	T295M	NONSYN	883	885	ACG	955	957	ATG	31;32;32	A;T;G	31;31;31	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1104	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2246	26.3	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1951	1953	CGC	21;21;21	C;G;C	21;21;21	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	546	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1266	23.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	932	934	ACC	10;10;10	A;C;C	9;10;10	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	546	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1266	23.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	944	946	TCG	15;14;14	T;C;G	15;14;14	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	513	416	baeR	723	521	97.7	baeR.l15.c17.ctg.1	686	25.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	513	416	baeR	723	191	97.91	baeR.l15.c17.ctg.2	326	12.3	0	.	p	.	0	S214F	NONSYN	640	642	TCT	108	110	TTT	17;17;16	T;T;T	17;17;16	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	816	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1631	26.0	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1341	1343	AAA	15;15;15	A;A;A	14;14;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	816	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1631	26.0	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1353	1355	GAG	13;12;12	G;A;G	10;11;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	816	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1631	26.0	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1359	1361	CAC	13;14;14	C;A;C	13;14;14	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	816	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1631	26.0	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1413	1415	GAG	24;24;24	G;A;G	24;24;24	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	539	1244	cpxA	1374	1374	98.76	cpxA.l15.c17.ctg.1	1781	37.5	0	.	p	.	0	A231T	NONSYN	691	693	GCG	894	896	ACG	31;31;31	A;C;G	31;31;31	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	539	796	cpxR	699	699	99.28	cpxR.l15.c4.ctg.1	1199	35.6	0	.	p	.	0	Q146E	NONSYN	436	438	CAG	665	667	GAG	52;52;52	G;A;G	52;52;52	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	712	cysB	975	975	99.28	cysB.l6.c30.ctg.1	1446	26.4	0	.	p	.	0	T132I	NONSYN	394	396	ACA	640	642	ATA	40;41;41	A;T,C;A	39;40,1;41	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	870	emrA	1173	1173	98.38	emrA.l15.c4.ctg.1	1629	28.7	0	.	p	.	0	I219V	NONSYN	655	657	ATC	884	886	GTC	26;26;26	G;T;C	26;26;25	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1274	emrB	1539	1539	99.81	emrB.l6.c30.ctg.1	2011	34.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	36	emrE_1	333	94	96.81	emrE_1.l15.c4.ctg.1	112	8.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	728	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1309	27.9	0	.	p	.	0	K176R	NONSYN	526	528	AAG	752	754	AGG	23;23;23	A;G;G	23;23;23	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	728	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1309	27.9	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1142	1144	GAC	22;22;22	G;A;C	22;22;22	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	432	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1006	23.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1084	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1967	29.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	420	evgA	615	615	99.19	evgA.l15.c4.ctg.1	1065	21.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	430	432	CTG	27;28;28	C;T;G	27;28;28	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	T38I	NONSYN	112	114	ACA	190	192	ATA	12;12;11	A;T;A	11;12;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	L42V	NONSYN	124	126	CTA	202	204	GTA	8;8;9	G;T;A	8;8;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	A93T	NONSYN	277	279	GCG	355	357	ACG	21;20;20	A;C;G	21;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	A114E	NONSYN	340	342	GCA	418	420	GAA	22;25;27	G;A;A	22;25;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	T127A	NONSYN	379	381	ACT	457	459	GCT	36;36;35	G;C;T	36;36;35	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	N133D	NONSYN	397	399	AAT	475	477	GAT	26;25;25	G;A;T	25;25;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	P162S	NONSYN	484	486	CCA	562	564	TCA	22;22;22	T;C;A	22;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	691	693	CAG	28;30;27	C;A,T;G	28;29,1;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	I251V	NONSYN	751	753	ATT	829	831	GTT	31;29;30	G;T;T	31;29;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	1034	97.2	evgS.l15.c30.ctg.1	1112	24.0	0	.	p	.	0	N303D	NONSYN	907	909	AAT	985	987	GAT	17;18;17	G;A;T	17;18;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	185	187	AAA	13;11;11	A;A;A	13;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	920	922	CAT	23;25;24	C;A;T	23;25;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	974	976	CAT	20;18;18	C;A;T	20;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	992	994	AGA	19;17;16	A;G;A,C	19;17;15,1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1007	1009	AAT	20;19;19	A;A;T	20;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1154	1156	TCC	12;11;10	T;C;C	12;11;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1319	1321	ATT	27;27;26	A;T;T	27;27;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1340	1342	GAT	17;16;17	G;A;T	17;16;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1454	1456	GTT	30;29;28	G;T;T	30;29;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2034	evgS	3594	2482	97.9	evgS.l15.c30.ctg.2	2657	30.2	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1739	1741	CAC	31;30;29	C;A;C	31;30;29	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	660	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1265	28.0	1	SNP	p	P64L	0	.	.	190	192	CCA	409	411	CCA	37;35;37	C;C;A	37;35;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	660	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1265	28.0	1	SNP	p	P64A	0	.	.	190	192	CCA	409	411	CCA	37;35;37	C;C;A	37;35;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	660	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1265	28.0	1	SNP	p	P64S	0	.	.	190	192	CCA	409	411	CCA	37;35;37	C;C;A	37;35;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	660	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1265	28.0	1	SNP	p	P64R	0	.	.	190	192	CCA	409	411	CCA	37;35;37	C;C;A	37;35;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	660	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1265	28.0	1	SNP	p	P64H	0	.	.	190	192	CCA	409	411	CCA	37;35;37	C;C;A	37;35;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	572	gadE	528	528	100.0	gadE.l6.c30.ctg.1	946	32.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	122	gadW	729	152	96.71	gadW.l15.c4.ctg.1	152	16.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	122	gadW	729	341	93.26	gadW.l15.c4.ctg.3	341	7.9	0	.	p	.	0	L46P	NONSYN	136	138	CTG	18	20	CCG	1;1;1	C;C;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	122	gadW	729	341	93.26	gadW.l15.c4.ctg.3	341	7.9	0	.	p	.	0	E54D	NONSYN	160	162	GAA	42	44	GAT	5;5;5	G;A;T	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	122	gadW	729	341	93.26	gadW.l15.c4.ctg.3	341	7.9	0	.	p	.	0	I88M	NONSYN	262	264	ATA	144	146	ATG	2;2;2	A;T;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	122	gadW	729	341	93.26	gadW.l15.c4.ctg.3	341	7.9	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	147	149	CCG	2;2;2	C;C;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	122	gadW	729	341	93.26	gadW.l15.c4.ctg.3	341	7.9	0	.	p	.	0	D100E	NONSYN	298	300	GAC	180	182	GAA	2;2;2	G;A;A	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	122	gadW	729	341	93.26	gadW.l15.c4.ctg.3	341	7.9	0	.	p	.	0	P101S	NONSYN	301	303	CCC	183	185	TCC	2;2;2	T;C;C	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	122	gadW	729	341	93.26	gadW.l15.c4.ctg.3	341	7.9	0	.	p	.	0	R102G	NONSYN	304	306	CGG	186	188	GGG	2;3;3	G;G;G	2;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	122	gadW	729	341	93.26	gadW.l15.c4.ctg.3	341	7.9	0	.	p	.	0	K110N	NONSYN	328	330	AAA	210	212	AAT	9;9;9	A;A;T	9;9;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	560	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1161	25.8	0	.	p	.	0	F53L	NONSYN	157	159	TTC	328	330	TTA	33;34;34	T;T;A	33;34;34	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	560	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1161	25.8	0	.	p	.	0	V79I	NONSYN	235	237	GTT	406	408	ATT	21;21;21	A,C;T;T	19,2;21;21	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	560	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1161	25.8	0	.	p	.	0	R246G	NONSYN	736	738	AGA	907	909	GGA	26;26;25	G;G;A	26;26;25	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	560	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1161	25.8	0	.	p	.	0	S248P	NONSYN	742	744	TCG	913	915	CCG	24;24;24	C;C;G	24;24;24	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2250	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3108	39.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2262	2264	GAA	39;40;43	G;A;A	37;40;43	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2250	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3108	39.0	1	SNP	p	S83W	0	.	.	247	249	TCG	477	479	TCG	41;40;40	T;C;G	40;40;40	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2250	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3108	39.0	1	SNP	p	S83I	0	.	.	247	249	TCG	477	479	TCG	41;40;40	T;C;G	40;40;40	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2250	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3108	39.0	1	SNP	p	S83L	0	.	.	247	249	TCG	477	479	TCG	41;40;40	T;C;G	40;40;40	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2250	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3108	39.0	1	SNP	p	D87V	0	.	.	259	261	GAC	489	491	GAC	39;40;40	G;A;C	38;39;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2250	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3108	39.0	1	SNP	p	D87N	0	.	.	259	261	GAC	489	491	GAC	39;40;40	G;A;C	38;39;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2250	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3108	39.0	1	SNP	p	D87Y	0	.	.	259	261	GAC	489	491	GAC	39;40;40	G;A;C	38;39;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2250	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3108	39.0	1	SNP	p	D87H	0	.	.	259	261	GAC	489	491	GAC	39;40;40	G;A;C	38;39;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2250	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3108	39.0	1	SNP	p	D87G	0	.	.	259	261	GAC	489	491	GAC	39;40;40	G;A;C	38;39;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2246	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2937	41.0	1	SNP	p	R136E	0	.	.	406	408	CGC	672	674	CGC	47;47;46	C;G,C,T;C	46;45,1,1;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2246	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2937	41.0	1	SNP	p	R136G	0	.	.	406	408	CGC	672	674	CGC	47;47;46	C;G,C,T;C	46;45,1,1;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2246	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2937	41.0	1	SNP	p	R136H	0	.	.	406	408	CGC	672	674	CGC	47;47;46	C;G,C,T;C	46;45,1,1;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2246	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2937	41.0	1	SNP	p	R136L	0	.	.	406	408	CGC	672	674	CGC	47;47;46	C;G,C,T;C	46;45,1,1;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2246	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2937	41.0	1	SNP	p	R136S	0	.	.	406	408	CGC	672	674	CGC	47;47;46	C;G,C,T;C	46;45,1,1;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2246	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2937	41.0	1	SNP	p	R136I	0	.	.	406	408	CGC	672	674	CGC	47;47;46	C;G,C,T;C	46;45,1,1;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2246	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2937	41.0	1	SNP	p	R136C	0	.	.	406	408	CGC	672	674	CGC	47;47;46	C;G,C,T;C	46;45,1,1;46	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	362	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	1054	18.4	0	.	p	.	0	A72P	NONSYN	214	216	GCG	438	440	CCG	24;23;22	C;C;G	24;23;22	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	362	kdpE	678	678	98.08	kdpE.l15.c30.ctg.1	1054	18.4	0	.	p	.	0	T123A	NONSYN	367	369	ACC	591	593	GCC	24;25;24	G;C;C	24;24;24	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	828	leuO	945	945	99.26	leuO.l6.c17.ctg.1	1297	34.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	205	207	TCA	23;22;22	T;C;A	23;22;22	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	288	marA	384	384	99.74	marA.l15.c4.ctg.1	840	18.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	460	462	AGC	19;18;17	A;G;C	19;18;17	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	562	564	CAT	5;5;5	C;A;T	3;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	V45E	0	.	.	133	135	GTG	286	288	GTG	26;26;26	G;T;G	26;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	I49S	0	.	.	145	147	ATC	298	300	ATC	27;26;24	A;T;C	26;25;23	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	A70T	0	.	.	208	210	GCA	361	363	GCA	17;17;17	G;C;A	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	R73S	0	.	.	217	219	CGT	370	372	CGT	17;17;17	C;G;T	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	R73C	0	.	.	217	219	CGT	370	372	CGT	17;17;17	C;G;T	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	R77C	0	.	.	229	231	CGC	382	384	CGC	18;17;17	C;G;C	18;17;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	R77L	0	.	.	229	231	CGC	382	384	CGC	18;17;17	C;G;C	18;17;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	L78M	0	.	.	232	234	CTG	385	387	CTG	17;17;15	C;T;G	17;17;15	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	R94S	0	.	.	280	282	CGC	433	435	CGC	16;16;17	C;G,T;C	16;15,1;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	R94H	0	.	.	280	282	CGC	433	435	CGC	16;16;17	C;G,T;C	16;15,1;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	184	marR	435	435	97.7	marR.l15.c30.ctg.1	732	12.7	1	SNP	p	V96E	0	.	.	286	288	GTA	439	441	GTA	17;17;19	G;T;A	16;17;18	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	S7F	NONSYN	19	21	TCC	4	6	TTC	1;1;1	T;T;C	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	R36I	NONSYN	106	108	AGG	91	93	ATC	17;16;14	A;T;C	17;16;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	E42A	NONSYN	124	126	GAA	109	111	GCC	5;5;5	G;C;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	N43V	NONSYN	127	129	AAT	112	114	GTG	5;5;5	G;T;G	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	E52D	NONSYN	154	156	GAG	139	141	GAT	12;12;12	G;A;T	12;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	N59T	NONSYN	175	177	AAC	160	162	ACC	9;10;10	A;C;C	9;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	I68L	NONSYN	202	204	ATA	187	189	TTA	11;10;10	T;T;A	11;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	328	330	CAG	27;24;24	C;A;G	27;24;24	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	D128A	NONSYN	382	384	GAC	367	369	GCC	21;22;22	G;C;C	21;22;21	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	S163A	NONSYN	487	489	TCG	472	474	GCG	20;20;22	G;C;G	20;20;22	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	L231V	NONSYN	691	693	CTT	676	678	GTT	15;14;14	G;T;T	12;14;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	588	mdfA	1233	1218	96.96	mdfA.l15.c4.ctg.1	1449	21.2	0	.	p	.	0	R285fs	FSHIFT	853	853	C	838	838	C	23	C	23	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	594	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1426	21.2	0	.	p	.	0	V12trunc	TRUNC	34	34	G	67	67	G	29	G	29	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	594	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1426	21.2	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	124	126	CAG	10;9;9	C;A;G	10;9;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	594	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1426	21.2	0	.	p	.	0	T83I	NONSYN	247	249	ACC	274	276	ATC	14;13;13	A;T;C	14;13;13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	594	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1426	21.2	0	.	p	.	0	I99M	NONSYN	295	297	ATA	322	324	ATG	13;14;14	A;T;G	13;14;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	594	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1426	21.2	0	.	p	.	0	A130T	NONSYN	388	390	GCC	415	417	ACC	21;22;22	A;C;C	21;22;22	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2230	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3493	34.3	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1957	1959	ACC	54;52;55	A;C;C	54;52;54	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2230	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3493	34.3	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2350	2352	CAA	22;23;23	C;A;A	21;23;22	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2230	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3493	34.3	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2518	2520	ATT	22;22;21	A;T;T	22;22;21	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2230	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3493	34.3	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2602	2604	GTT	37;39;41	G;T,C;T	37;37,1;41	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2230	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3493	34.3	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2710	2712	GAG	18;20;22	G;A;G	18;20;22	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2230	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3493	34.3	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2938	2940	ATG	28;28;28	A;T;G	28;27;28	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2230	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3493	34.3	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3073	3075	GAT	26;24;25	G;A;T	26;24;25	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1914	mdtC	3078	2896	98.72	mdtC.l6.c30.ctg.1	2896	33.6	0	.	p	.	0	T22P	NONSYN	64	66	ACC	5	7	CCC	3;3;3	C,A;C;C	0,1;3;3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1914	mdtC	3078	2896	98.72	mdtC.l6.c30.ctg.1	2896	33.6	0	.	p	.	0	I46M	NONSYN	136	138	ATC	77	79	ATG	20;21;20	A;T;G	20;21;20	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1914	mdtC	3078	2896	98.72	mdtC.l6.c30.ctg.1	2896	33.6	0	.	p	.	0	V208I	NONSYN	622	624	GTC	563	565	ATC	28;30;30	A;T;C	27;29;29	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1914	mdtC	3078	2896	98.72	mdtC.l6.c30.ctg.1	2896	33.6	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	2879	2881	CAC	4;4;4	C;A;C	3;4;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	918	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1878	26.3	0	.	p	.	0	D3E	NONSYN	7	9	GAT	230	232	GAA	13;13;13	G;A;A	12;13;13	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	918	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1878	26.3	0	.	p	.	0	T226A	NONSYN	676	678	ACG	899	901	GCG	25;25;24	G;C;G	25;25;24	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	918	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1878	26.3	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1241	1243	ATC	33;32;32	A;T;C	31;31;31	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	918	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1878	26.3	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1544	1546	TTT	32;32;31	T;T;T	32;32;31	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1186	mdtE	1158	1158	99.31	mdtE.l6.c4.ctg.1	1645	38.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2918	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3623	43.4	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1173	1175	ACC	36;36;36	A;C;C	36;30;35	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2918	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3623	43.4	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2415	2417	GAC	52;50;47	G;A;C	52;48;46	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	936	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1530	26.4	0	.	p	.	0	V200I	NONSYN	598	600	GTC	637	639	ATC	35;36;37	A;T;C	35;36;37	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	936	mdtG	1227	159	99.37	mdtG.l15.c30.ctg.2	159	28.5	0	.	p	.	0	E5G	NONSYN	13	15	GAA	3	5	GGA	2;4;4	G;G;A	2;4;4	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	666	mdtH	1209	1209	98.1	mdtH.l6.c30.ctg.1	1554	22.9	0	.	p	.	0	G134C	NONSYN	400	402	GGT	580	582	TGT	35;36;37	T;G;T	35;36;37	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	666	mdtH	1209	1209	98.1	mdtH.l6.c30.ctg.1	1554	22.9	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1150	1152	TTG	19;20;20	T;T;G	19;20;20	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	666	mdtH	1209	1209	98.1	mdtH.l6.c30.ctg.1	1554	22.9	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1255	1257	CAG	9;9;10	C;A;G	9;9;10	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	666	mdtH	1209	1209	98.1	mdtH.l6.c30.ctg.1	1554	22.9	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1360	1362	ACG	9;9;9	A;C;G	9;9;9	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1062	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1644	34.7	0	.	p	.	0	A185S	NONSYN	553	555	GCC	765	767	TCC	27;28;28	T;C;C	24;26;28	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	636	mdtN	1032	1032	98.16	mdtN.l6.c30.ctg.1	1468	23.1	0	.	p	.	0	V119I	NONSYN	355	357	GTT	578	580	ATT	27;27;27	A;T;T	27;27;27	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	208	210	ATG	17;17;17	A;T;G	17;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	274	276	ATC	27;27;26	A;T;C	27;27;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	523	525	CGC	43;43;41	C;G;C	42;43;40	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	889	891	AGC	40;40;41	A;G;C	39;39;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1090	1092	GTG	34;37;37	G;T;G	34;36;36	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1153	1155	AAC	12;13;13	A;A;C	11;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1198	1200	GTC	38;38;38	G;T;C	36;37;38	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1228	1230	ATA	50;49;48	A;T;A	49;49;48	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1336	1338	TCT	24;23;24	T;C;T	24;22;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1723	1725	GCG	38;39;39	G;C;G	37;39;38	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1582	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2448	34.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1936	1938	ATC	35;35;34	A;T;C	35;35;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	958	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	1639	30.6	0	.	p	.	0	S129A	NONSYN	385	387	TCA	554	556	GCG	20;20;21	G;C;G	19;20;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	958	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	1639	30.6	0	.	p	.	0	A187T	NONSYN	559	561	GCC	728	730	ACC	31;33;31	A;C;C	31;33;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	958	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	1639	30.6	0	.	p	.	0	H211R	NONSYN	631	633	CAC	800	802	CGC	28;29;29	C;G;C	28;29;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	958	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	1639	30.6	0	.	p	.	0	V250A	NONSYN	748	750	GTT	917	919	GCT	33;34;35	G,C;C,G;T	32,1;33,1;35	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	958	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	1639	30.6	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1001	1003	AAA	17;17;17	A;A;A	17;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	958	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	1639	30.6	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1019	1021	CGA	20;20;21	C;G;A	20;20;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	958	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	1639	30.6	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1184	1186	GCC	29;29;27	G;C;C	29;29;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	958	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	1639	30.6	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1196	1198	GAT	21;20;21	G;A;T	21;20;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	958	mdtP	1467	1467	97.96	mdtP.l15.c17.ctg.1	1639	30.6	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1613	1615	GCT	11;11;10	G;C;T	11;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2140	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3877	29.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1507	1509	AAG	26;26;25	A;A;G	26;26;25	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2140	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3877	29.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2584	2586	CTG	38;38;37	C;T;G	38;38;37	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	166	mgrB	144	144	100.0	mgrB.l15.c4.ctg.1	163	27.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1476	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2143	37.1	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1025	1027	AAC	40;40;40	A;A;C	40;40;40	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1476	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2143	37.1	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1571	1573	ATA	38;41;43	A;T;A	38;41;43	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1192	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1725	37.1	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1243	1245	GTG	34;36;39	G;T;G	34;36;39	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1192	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1725	37.1	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1321	1323	GAT	61;58;57	G;A;T	61;58;57	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1192	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1725	37.1	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1324	1326	CTG	57;54;52	C;T;G	57;54;52	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	428	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1157	19.7	0	.	p	.	0	R27C	NONSYN	79	81	CGT	287	289	TGT	19;19;17	T;G;T	19;19;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	428	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1157	19.7	0	.	p	.	0	I117T	NONSYN	349	351	ATC	557	559	ACC	31;32;32	A;C;C	31;32;32	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	428	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1157	19.7	0	.	p	.	0	G187D	NONSYN	559	561	GGC	767	769	GAC	30;29;30	G;A;C	30;29;30	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	428	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1157	19.7	1	SNP	p	R15C	0	.	.	43	45	CGC	251	253	CGC	29;27;26	C;G;C	29;27;26	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	428	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1157	19.7	1	SNP	p	S33R	0	.	.	97	99	AGC	305	307	AGC	17;17;17	A;G;C	17;17;17	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	428	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1157	19.7	1	SNP	p	G131D	0	.	.	391	393	GGC	599	601	GGC	29;29;29	G;G;C	28;28;27	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	428	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1157	19.7	1	SNP	p	R203L	0	.	.	607	609	CGT	815	817	CGT	32;31;31	C;G;T	31;31;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	428	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1157	19.7	1	SNP	p	R203C	0	.	.	607	609	CGT	815	817	CGT	32;31;31	C;G;T	31;31;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1016	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1524	35.6	1	SNP	p	G141D	0	.	.	421	423	GGT	657	659	GGT	49;47;47	G;G;T	49;46;47	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1016	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1524	35.6	1	SNP	p	G141E	0	.	.	421	423	GGT	657	659	GGT	49;47;47	G;G;T	49;46;47	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1016	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1524	35.6	1	SNP	p	R154A	0	.	.	460	462	CGT	696	698	CGT	45;46;44	C;G;T	44;46;44	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1016	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1524	35.6	1	SNP	p	R154D	0	.	.	460	462	CGT	696	698	CGT	45;46;44	C;G;T	44;46;44	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2082	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2651	42.2	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1834	1836	TCG	49;48;50	T;C;G	46;46;48	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2082	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2651	42.2	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2449	2451	AAC	22;22;21	A;A;C	22;22;21	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2082	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2651	42.2	1	SNP	p	A85T	0	.	.	253	255	GCG	463	465	GCG	37;40;41	G;C;G	36;36;36	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2082	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2651	42.2	1	SNP	p	D111H	0	.	.	331	333	GAT	541	543	GAT	35;37;37	G;A;T	35;37;37	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2082	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2651	42.2	1	SNP	p	S129P	0	.	.	385	387	TCC	595	597	TCC	41;40;41	T;C;C	40;40;41	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	1254	parE_1	1893	1750	97.49	parE_1.l15.c4.ctg.1	1949	30.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1283	1285	GAT	48;48;49	G;A;T	48;48;49	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	1254	parE_1	1893	154	98.05	parE_1.l15.c4.ctg.3	199	23.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1174	patA	1380	1380	99.86	patA.l15.c30.ctg.1	1846	34.1	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1290	1292	GAT	37;36;36	G;A,G;T	37;34,1;36	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	V146F	0	.	.	436	438	GTT	688	690	GTT	58;57;56	G;T;T	58;57;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1789	1791	CAG	44;43;42	C;A;G	44;43;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1789	1791	CAG	44;43;42	C;A;G	44;43;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1828	1830	CAC	46;46;47	C;A;C	46;46;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1837	1839	CGT	42;40;40	C;G;T	42;40;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1837	1839	CGT	42;40;40	C;G;T	42;40;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1843	1845	TCC	37;37;38	T;C;C	37;37;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1849	1851	CTC	39;38;39	C;T;C	39;38;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1939	1941	ACC	59;60;61	A;C;C	59;60;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1942	1944	CCT	59;57;57	C;C;T	59;57;57	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4234	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4542	50.2	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2311	2313	CGT	81;80;79	C;G;T	81;80;79	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	.	n	.	0	A226G	SNP	226	226	A	465	465	G	378	G	377	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	1	SNP	n	A794T	0	.	.	794	794	A	1033	1033	A	259	A	256	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	1	SNP	n	A794G	0	.	.	794	794	A	1033	1033	A	259	A	256	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	1	SNP	n	G926T	0	.	.	926	926	G	1165	1165	G	287	G	286	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	1	SNP	n	G926C	0	.	.	926	926	G	1165	1165	G	287	G	286	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	1	SNP	n	G926A	0	.	.	926	926	G	1165	1165	G	287	G	286	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	1	SNP	n	A1519T	0	.	.	1519	1519	A	1758	1758	A	293	A	292	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	1	SNP	n	A1519C	0	.	.	1519	1519	A	1758	1758	A	293	A	292	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	1	SNP	n	A1519G	0	.	.	1519	1519	A	1758	1758	A	293	A	292	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	T1010C	.	1010	1010	T	1249	1249	T	315	T,C	228,81	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	C183T,A	.	183	183	C	422	422	C	281	C,T,A	196,80,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	T90C	.	90	90	T	329	329	T	282	T,C	213,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	A250T	.	250	250	A	489	489	A	352	A,T	269,79	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	G474A	.	474	474	G	713	713	G	342	G,A	263,74	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	A253T	.	253	253	A	492	492	A	344	A,T	263,79	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	C719T,A	.	719	719	C	958	958	C	262	C,T,A	155,104,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	C194T,A	.	194	194	C	433	433	C	305	C,T,A	247,55,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	C1038T	.	1038	1038	C	1277	1277	C	297	C,T	225,70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	G1002A	.	1002	1002	G	1241	1241	G	315	G,A	229,86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	G1006C	.	1006	1006	G	1245	1245	G	311	G,C	229,77	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	A79G	.	79	79	A	318	318	A	270	A,G	198,71	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	C624T	.	624	624	C	863	863	C	246	C,T	208,38	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	10040	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1976	266.7	0	HET	.	.	.	T273A	.	273	273	T	512	512	T	311	T,A	233,73	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	490	soxR	465	465	100.0	soxR.l15.c4.ctg.1	882	29.8	1	SNP	p	R20H	0	.	.	58	60	CGC	250	252	CGC	42;42;41	C;G;C	42;42;40	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	490	soxR	465	465	100.0	soxR.l15.c4.ctg.1	882	29.8	1	SNP	p	G121D	0	.	.	361	363	GGT	553	555	GGT	36;38;40	G;G;T	36;38;39	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	310	soxS_1	324	324	99.69	soxS_1.l15.c17.ctg.1	823	20.1	1	SNP	p	A12S	0	.	.	34	36	GCA	271	273	GCA	49;48;49	G;C;A	49;48;49	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1424	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	1981	38.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
